Nuveen Dow 30 Dynamic Overwrite Fund
DIAX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11 | $13 | $40 | $92 |
| % Growth | -10.9% | -68.1% | -57.1% | – |
| Cost of Goods Sold | $0 | $0 | $5 | $0 |
| Gross Profit | $11 | $13 | $34 | $92 |
| % Margin | 100% | 100% | 86.6% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6 | $5 | $0 | $0 |
| SG&A Expenses | $6 | $5 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $5 | $0 | $0 |
| Operating Income | $6 | $7 | -$27 | $92 |
| % Margin | 50.4% | 57% | -68.9% | 99.5% |
| Other Income/Exp. Net | $55 | $35 | $0 | $0 |
| Pre-Tax Income | $61 | $43 | -$27 | $92 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $61 | $43 | -$27 | $92 |
| % Margin | 543% | 337.9% | -68.9% | 99.5% |
| EPS | 1.68 | 1.17 | -0.75 | 2.53 |
| % Growth | 43.6% | 256% | -129.6% | – |
| EPS Diluted | 1.68 | 1.17 | -0.75 | 2.53 |
| Weighted Avg Shares Out | 36 | 36 | 36 | 36 |
| Weighted Avg Shares Out Dil | 36 | 36 | 36 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$6 | -$7 | -$7 | -$6 |
| EBITDA | $0 | $43 | -$27 | $92 |
| % Margin | 0% | 337.9% | -68.9% | 99.5% |